Short-Term Outcomes of Inflammatory Bowel Disease after Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

Heshmati, Keyvan; Lo, Tammy; Tavakkoli, Ali; Sheu, Eric G.

doi:10.1016/j.jamcollsurg.2019.01.021

Cited by 31 publications

(27 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based on the inclusion/exclusion criteria, 14 observational studies were finalized for analysis (Figure 1). 11,17‐29 All studies were published after 2013. Of the included studies, nine were published as full manuscripts 11,17‐24 and five were published as abstracts 25‐29 .…”

Section: Resultsmentioning

confidence: 99%

“… 11,17‐29 All studies were published after 2013. Of the included studies, nine were published as full manuscripts 11,17‐24 and five were published as abstracts 25‐29 . One study each originated from the Netherlands 17 and Israel, 22 while the remaining 12 were from United States 11,18‐21,23‐29 .…”

Section: Resultsmentioning

confidence: 99%

“…Nine studies reported data regarding treatment for patients with IBD 11,17,18,20‐23,28,29 . Out of 330 patients, 178 (53.9%) patients were receiving some sort of treatment for their IBD: 33 (13.6%) of 242 patients (six studies) received steroids, 17,18,21‐23,29 126 (40.6%) of 310 patients (eight studies) received immunomodulators/anti‐inflammatory 17,18,20‐23,28,29 and 41 (13.1%) of 314 patients (eight studies) received biologics at the time of surgery 17,18,20‐23,25,29 …”

Section: Resultsmentioning

confidence: 99%

“…Ten studies reported data on the type of bariatric surgery in patients with IBD 11,17,18,20‐25,28 . Of 727 total patients, 342 (47.0%) patients underwent SG, 120 (16.5%) underwent GB, 256 (35.2%) patients underwent RYGB and 9 (1.2%) patients underwent other surgeries.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis

et al. 2020

View full text Add to dashboard Cite

Summary The efficacy of bariatric surgery in achieving weight loss and preventing long‐term comorbidities such as cardiovascular diseases, diabetes mellitus and osteoarthritis is well established. Data regarding safety of bariatric surgery in patients with inflammatory bowel disease (IBD) is scarce. We attempted a systematic review and meta‐analysis to evaluate the complications following bariatric surgery in patients with IBD. The primary outcomes evaluated were wound infection, Clavien‐Dindo grade > II complications and IBD exacerbation (within 1 year). Secondary outcomes evaluated included overall mortality, stricture, small bowel obstruction, acute kidney injury (AKI) and thromboembolism. Pooled outcomes (event rate) with 95% confidence interval (CI) were calculated using random effects model. A total of 14 studies (all observational) with 2608 patients were included. The rates of primary outcomes were: wound infection (4.1%, 95% CI: 0.9‐7.2), Clavien‐Dindo grade > II complications (2.0%, 95%: CI 0.6‐3.5) and IBD exacerbation (4.3%, 95% CI: 0.7‐7.9). The pooled rate for other outcomes was: mortality 0.1%, stricture 6.5%, small bowel obstruction 6.7%, AKI 2.2% and thromboembolism 0.1%. Bariatric surgery is relatively safe in patients with IBD and should be pursued to reduce comorbidities associated with obesity. Future comparative studies are needed to further assess the safety of bariatric surgery in population with and without IBD.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis

et al. 2020

View full text Add to dashboard Cite

show abstract

“…However, in CD patients, RYGB was associated with a greater number of patients with increased IBD-medication requirements. SG led to less weight loss but had a lower rate of severe complications compared to RYGB [92]. The gastric balloon may be a safe alternative for weight loss in IBD patients.…”

Section: Treatment Focal Pointsmentioning

confidence: 89%

Nonalcoholic Fatty Liver Disease and Inflammatory Bowel Disease: Complex Interactions, Evaluations, and Management Decisions

Sadowski¹,

Ordway²,

Bobeck³

et al. 2019

obm hg

View full text Add to dashboard Cite

Diseases of the liver are commonly encountered in patients with inflammatory bowel disease (IBD). While the differential diagnosis for IBD patients with elevated liver associated enzymes is broad, it is similar to that of the general population, including nonalcoholic fatty liver disease (NAFLD): The most common liver disease in North America. When initial workup for elevated liver associated enzymes is negative and patients have steatosis on ultrasound, we counsel IBD patients aggressively about weight loss in order to prevent the progression of liver disease. Here, we describe the association between liver disease and IBD and illustrate an approach to management of elevated liver associated enzymes in this unique patient population.

show abstract

Essential updates 2018/2019: Colorectal (benign)

Ogino

Mizushima

Matsuda

et al. 2019

Annals of Gastroent Surgery

View full text Add to dashboard Cite

This review outlines current topics on the surgical treatment of benign colorectal diseases, with a focus on inflammatory bowel disease (IBD) and diverticulitis. Treatment options for IBD and diverticulitis have evolved in the last few years as a result of medical advances in technology and new clinical trials. Therefore, treatment options and strategies need to be updated to provide optimal care for patients. The purpose of this review is to elucidate recent global trends and update the surgical treatment strategy for IBD and diverticulitis based on literature published in the past 2 years. Prevalence of IBD, including ulcerative colitis and Crohn's disease, has increased over the last few decades. During this period, many new medical therapies were introduced for the treatment of IBD, including biological therapy, immunomodulators, and leukocyte apheresis therapy. As a result, new surgical strategies for IBD are required. In order to improve surgical outcomes in IBD patients, the influence of preoperative treatment on postoperative complications needs to be considered. The incidence of diverticulitis is also increasing with lifestyle changes and increasing numbers of older people. For diverticulitis with perforation and generalized peritonitis, surgery is the gold standard. Elective surgery after conservative treatment of diverticulitis is also an option because of high recurrence rates. With an increase in diverticulitis, systematic strategies are essential for an appropriate approach to diverticulitis, taking into account various factors, including the patient's background.

show abstract

Short-Term Outcomes of Inflammatory Bowel Disease after Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

Cited by 31 publications

References 46 publications

Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis

Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis

Nonalcoholic Fatty Liver Disease and Inflammatory Bowel Disease: Complex Interactions, Evaluations, and Management Decisions

Essential updates 2018/2019: Colorectal (benign)

Contact Info

Product

Resources

About